Showing results (231-240 of 287) with videos related to

Sort By:
Pageof 29
The Journal of Antimicrobial Chemotherapy|September 1, 1988
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacinH Lode, G Höffken, P Olschewski, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1987
Pharmacokinetics of ofloxacin after parenteral and oral administrationH Lode, G Höffken, P Olschewski, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Comparative pharmacokinetics of glycopeptide antibiotics, and the influence of teicoplanin on granulocyte functionH Lode, M Boeckh, G Höffken, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 2000
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microfloraG Beyer, M Hiemer-Bau, S Ziege, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 1, 1995
[BiPAP therapy of respiratory disorders in patients with congenital neuromuscular diseases]H Müller-Pawlowski, A von Moers, M Raffenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1992
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989H F Geerdes, D Ziegler, H Lode, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 15, 2004
Antiviral treatment and prophylaxis of influenza in primary care: German recommendationsP Wutzler, K-D Kossow, H Lode, et al.
Respiratory Medicine|October 17, 2003
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumoniaH Lode, C Grossman, S Choudhri, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial speciesH F Geerdes-Fenge, A Wiedersich, S Wagner, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Urinary recovery and tolerability of FCE 22101 following single intravenous administration under restricted and high fluid intakeD Sassella, G Cassinelli, R Corigli, et al.
Pageof 29